title: Cerebral white matter and retinal arterial health in hypertension and type 2 diabetes mellitus.
abstract: We examined 33 hypertensive (22 with comorbid type 2 diabetes mellitus (T2DM)) and 29 normotensive (8 with T2DM) middle-aged and elderly adults, comparable in age and education. Relative to normotensive participants, those with hypertension, in addition to a higher prevalence of periventricular white matter (WM) lesions, had significantly lower WM microstructural integrity of major fiber tracts as seen with MRI-based diffusion tensor imaging. Among participants with hypertension, those with co-morbid T2DM (n = 22) had more widespread WM pathology than those without T2DM (n = 11). Furthermore and consistent with previous research, both hypertension and T2DM were related to decreased retinal arterial diameter. Further exploratory analysis demonstrated that the observed retinal arteriolar narrowing among individual with hypertension was associated with widespread subclinical losses in WM microstructural integrity and these associations were present predominantly in the frontal lobe. We found that T2DM adds to the damaging effects of hypertension on cerebral WM, and notably these effects were independent of age and body mass index. Given that the decrease in retinal arteriolar diameter may be a biomarker for parallel pathology in cerebral arterioles, our data suggest that the frontal lobe may be particularly vulnerable to microvascular damage in the presence of hypertension and T2DM.
authors: Brain, Obesity, and Diabetes Laboratory (BODyLab), Department of Psychiatry, New York University School of Medicine, 145 East 32nd Street, 8th Floor, New York, NY 10016, USA.
authors: P L
authors: PL
authors: Yau
authors: R
authors: R
authors: Hempel
authors: A
authors: A
authors: Tirsi
authors: A
authors: A
authors: Convit
references: Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2060-7
references: 22895667
references: Clin Exp Hypertens A. 1982;4(7):1193-201
references: 6749344
references: Diabetologia. 2007 Apr;50(4):711-9
references: 17334649
references: J Clin Endocrinol Metab. 2005 Jun;90(6):3262-7
references: 15784710
references: Diabetologia. 2003 Dec;46(12):1604-10
references: 14595538
references: Neurobiol Dis. 2011 Jun;42(3):446-58
references: 21324363
references: J Anat. 2005 Apr;206(4):319-48
references: 15817102
references: Curr Eye Res. 2003 Sep;27(3):143-9
references: 14562179
references: J Neurol Sci. 1993 Jan;114(1):7-12
references: 8433101
references: Acta Neurol Scand. 2009 Apr;119(4):261-8
references: 18798828
references: Int J Clin Pract. 2007 Feb;61(2):269-80
references: 17263714
references: J Neurol Sci. 2007 Jan 31;252(2):159-62
references: 17182058
references: Obesity (Silver Spring). 2013 Dec;21(12):E577-85
references: 23512847
references: Psychiatry Res. 2009 Dec 30;174(3):223-30
references: 19906514
references: J Neurol Sci. 2012 Nov 15;322(1-2):206-10
references: 22687956
references: J Cardiometab Syndr. 2007 Spring;2(2):124-30
references: 17684469
references: Stroke. 2009 Dec;40(12):3869-71
references: 19850898
references: Hypertension. 2007 Jun;49(6):1228-34
references: 17404188
references: Neuroimage. 2010 Feb 1;49(3):2083-93
references: 19850136
references: Chin Med J (Engl). 2006 Aug 5;119(15):1304-7
references: 16919191
references: Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1217-28
references: 10752963
references: Hypertension. 2006 Feb;47(2):189-94
references: 16380526
references: Stroke. 2003 May;34(5):1126-9
references: 12690219
references: Ophthalmology. 2009 Jun;116(6):1175-81
references: 19376581
references: Neurology. 2002 Nov 26;59(10):1536-40
references: 12451193
references: Curr Opin Pharmacol. 2007 Dec;7(6):638-42
references: 18024186
references: Stroke. 2010 Dec;41(12):2801-6
references: 21030696
references: MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):103-8
references: 21293325
references: Neuroimage. 2009 Feb 15;44(4):1247-58
references: 19027860
references: Brain Res. 2011 Feb 10;1373:101-9
references: 21146506